Welcome to the AD/PD™ 2022 Interactive Program

The conference will officially run on Central European Time (CET) - Barcelona Time

To convert the conference times to your local time Click Here



 

148 Sessions

Sort By Relevance
SPONSORED SYMPOSIUM
Session Type
SPONSORED SYMPOSIUM
Date
Wed, 16.03.2022
Session Time
02:00 PM - 03:40 PM
Room
ONSITE PLENARY: 115-117
Session Description
The future of AD and PD – reaching beyond symptom control -Supported by Novo Nordisk

Session Description:

This symposium will introduce the need for new treatments for Alzheimer’s disease and Parkinson’s disease that go beyond symptomatic control and potentially treat the underlying causes of each disease. During this session, the pathophysiology of Alzheimer’s disease will be examined and drug targets other than amyloid and tau considered, including key data published on these targets to date. There will also be a presentation on neuroinflammation as an aspect of neurodegenerative diseases and a potential target for the treatment of both Alzheimer’s disease and Parkinson’s disease. Finally current treatments for Parkinson’s disease will be discussed briefly, as well as treatments currently being investigated in clinical trials, to provide a perspective on how the treatment landscape may change from symptomatic control to treatment in the future. These topics will be discussed by the expert faculty, who will also address any questions from attendees.

OTHER EVENT

ONSITE WELCOME RECEPTION IN THE EXHIBITION

Session Type
OTHER EVENT
Date
Wed, 16.03.2022
Session Time
07:40 PM - 08:40 PM
Room
.
PLENARY LECTURE
Session Type
PLENARY LECTURE
Date
Thu, 17.03.2022
Session Time
08:30 AM - 09:00 AM
Room
ONSITE PLENARY: 115-117
SPONSORED SYMPOSIUM
Session Type
SPONSORED SYMPOSIUM
Date
Tue, 15.03.2022
Session Time
09:05 AM - 11:05 AM
Room
ON-DEMAND-VIRTUAL GALLERY
Session Description
Targeting Perspectives on Alzheimer’s disease: underlying pathology and its impact on people living with the disease- Supported by Biogen

Session Description:

We invite you to join our eminent faculty in this Biogen symposium where we will discuss new perspectives on Alzheimer’s disease pathophysiology, explore what matters to people living with Alzheimer’s disease, and have a case-based discussion where we seek to translate our evolving understanding into clinical care. We look forward to welcoming you to what promises to be an insightful symposium.

Session Type
SYMPOSIUM
Date
Thu, 17.03.2022
Session Time
09:10 AM - 11:10 AM
Room
ONSITE: 114
Session Type
SYMPOSIUM
Date
Thu, 17.03.2022
Session Time
05:15 PM - 07:15 PM
Room
ONSITE: 113
Session Type
SYMPOSIUM
Date
Thu, 17.03.2022
Session Time
09:10 AM - 10:40 AM
Room
ONSITE: 133-134
Session Type
SYMPOSIUM
Date
Thu, 17.03.2022
Session Time
09:10 AM - 11:10 AM
Room
ONSITE: 113
SPONSORED SYMPOSIUM
Session Type
SPONSORED SYMPOSIUM
Date
Thu, 17.03.2022
Session Time
02:45 PM - 03:45 PM
Room
ONSITE PLENARY: 115-117
Session Description
How can the use of Alzheimer’s Disease diagnostic biomarkers in clinical practice help identify appropriate patients for future Disease Modifying Therapy? - Supported by Eli Lilly

Session Description:

During the symposium Dr Lleo and Dr Palmqvist will discuss the currently available Alzheimer’s Disease diagnostic biomarkers and their usefulness in clinical practice. They will look to the future and share the latest data on possible new Alzheimer’s Disease diagnostic biomarkers and their potential use in clinical practice. After sharing the data, the speakers will present clinical cases to highlight the clinical implications of Alzheimer’s Disease diagnostic biomarkers now & in the future. There will be time allocated for a question-and-answer session to explore further the area of diagnostic biomarkers as an enabler of Alzheimer’s disease treatment

Session Type
SYMPOSIUM
Date
Thu, 17.03.2022
Session Time
02:45 PM - 04:45 PM
Room
ONSITE: 112
Session Type
SYMPOSIUM
Date
Thu, 17.03.2022
Session Time
02:45 PM - 04:45 PM
Room
ONSITE: 114